These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8464035)

  • 1. Synthesis and pharmacological evaluation of (nitrooxy)alkyl apovincaminates.
    Kawashima Y; Ikemoto T; Horiguchi A; Hayashi M; Matsumoto K; Kawarasaki K; Yamazaki R; Okuyama S; Hatayama K
    J Med Chem; 1993 Apr; 36(7):815-9. PubMed ID: 8464035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of vinca alkaloids and related compounds. Part 84. Sulfonamide derivatives of some vinca alkaloids with cardiovascular activity.
    Moldvai I; Temesvári-Major E; Szántay C; Tóth G; Kárpáti E; Szántay C
    Arch Pharm (Weinheim); 1997 Jun; 330(6):190-8. PubMed ID: 9264244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of VA-045 on peripheral and central circulation in anesthetized dogs.
    Yamada S; Yamaguchi K; Okuyama S
    Gen Pharmacol; 1995 Oct; 26(6):1419-24. PubMed ID: 7590141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
    Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
    Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic profile of a new cerebral vasodilator, vincamine and of one of its derivatives, apovincaminic acid ethylester (RGH-4405).
    Caravaggi AM; Sardi A; Baldoli E; Di Francesco GF; Luca TC
    Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):139-48. PubMed ID: 869636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Agents to improve cerebrovascular circulation and cerebral metabolism--brovincamine].
    Maeda T
    Nihon Rinsho; 1985 Feb; 43(2):389-91. PubMed ID: 3889412
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebral metabolic and hemodynamic activities of l-eburnamonine in the anesthetized dog. A comparison with vincamine.
    Lacroix P; Quiniou MJ; Linee P; Le Polles JB
    Arzneimittelforschung; 1979; 29(8):1094-101. PubMed ID: 40580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral metabolic, hemodynamic and antihypoxic properties of l-eburnamonine.
    Linée P; Lacroix P; Le Polles JB; Aurousseau M; Boulu R; Van den Driessche J; Albert O
    Eur Neurol; 1978; 17 Suppl 1():113-20. PubMed ID: 753626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular action of vincamine hydrochloride].
    Piacenza G; Pesce E; Marchini F
    Farmaco Prat; 1978 Jul; 33(7):306-18. PubMed ID: 744231
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of an acute infusion of vincamine and ethyl apovincaminate on cerebral blood flow in healthy volunteers.
    Lim CC; Cook PJ; James IM
    Br J Clin Pharmacol; 1980 Jan; 9(1):100-1. PubMed ID: 7356869
    [No Abstract]   [Full Text] [Related]  

  • 11. Eburnamine derivatives and the brain.
    Vas A; Gulyás B
    Med Res Rev; 2005 Nov; 25(6):737-57. PubMed ID: 16158388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of Vinpocetine derivatives.
    Pan BW; Shi Y; Li WC; Wang Q; Pan M; Wu Q; Fu HZ
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126472. PubMed ID: 31859156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine].
    Tamaki N; Matsumoto S
    Nihon Rinsho; 1985 Feb; 43(2):376-8. PubMed ID: 2987571
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular effects of brovincamine and possible mechanisms involved.
    Kushiku K; Katsuragi T; Mori R; Morishita H; Furukawa T
    Clin Exp Pharmacol Physiol; 1985; 12(2):121-30. PubMed ID: 4006317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hypocapnia applied to study the effect of vincamine on cerebral circulation.
    Palacios L; Roca J; Balasch J
    Arch Farmacol Toxicol; 1978 Aug; 4(2):261-4. PubMed ID: 727839
    [No Abstract]   [Full Text] [Related]  

  • 16. General and cerebral haemodynamic activity of ethyl apovincaminate.
    Kárpáti E; Szporny L
    Arzneimittelforschung; 1976; 26(10a):1908-12. PubMed ID: 1037212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of some of the pharmacological properties of the new eburnamenine derivative vindeburnol with those of vincamine, vinburnine, dihydroergotoxine mesilate and nicergoline.
    Barzaghi F; Dragonetti M; Formento ML; Gueniau C; Nencioni A; Mantegazza P
    Arzneimittelforschung; 1986 Oct; 36(10):1442-8. PubMed ID: 3814205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral antioedematous effect of Teproside and of some vincamine derivatives.
    Borzeix MG; Cahn J
    Int J Clin Pharmacol Res; 1984; 4(4):259-61. PubMed ID: 6500773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonine.
    Fandy TE; Abdallah I; Khayat M; Colby DA; Hassan HE
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):259-67. PubMed ID: 26666648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of bromvincamine and vincamine on regional cerebral blood flow and mental functions in patients with multi-infarct dementia.
    Hagstadius S; Gustafson L; Risberg J
    Psychopharmacology (Berl); 1984; 83(4):321-6. PubMed ID: 6436861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.